LGR5 and ovarian serous carcinoma: To verify the prognostic impact of LGR5, we performed additional survival analysis with an independent cohort using Kaplan–Meier plotter for ovarian serous carcinomas (n = 1104), an online tool for the validation of prognostic biomarker candidates based on transcriptome data28.